BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 21666115)

  • 1. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.
    Essick EE; Wilson RM; Pimentel DR; Shimano M; Baid S; Ouchi N; Sam F
    PLoS One; 2013; 8(7):e68697. PubMed ID: 23894332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
    PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
    Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
    J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
    Cao T; Gao Z; Gu L; Chen M; Yang B; Cao K; Huang H; Li M
    PLoS One; 2014; 9(8):e103793. PubMed ID: 25099270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
    Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
    Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
    Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction.
    Han X; Wang Y; Fu M; Song Y; Wang J; Cui X; Fan Y; Cao J; Luo J; Sun A; Zou Y; Hu K; Zhou J; Ge J
    J Cardiovasc Transl Res; 2020 Apr; 13(2):225-237. PubMed ID: 31621035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.
    Yang K; Xu X; Nie L; Xiao T; Guan X; He T; Yu Y; Liu L; Huang Y; Zhang J; Zhao J
    Toxicol Lett; 2015 Apr; 234(2):110-9. PubMed ID: 25703824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.